These medications include semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), exenatide (Byetta, Bydureon BCise), and tirzepatide (Mounjaro, Zepbound)though tirzepatide is technically a dual GIP/GLP-1 receptor agonist
BP 157 is a compound that is marketed to improve healing, recovery, reduce pain and improve function
The culprit is not a drug, not a processed food, and not a habit anyone warned you about, because it is sitting in a blue bottle next to
Journal of Physiology (Paris), 91(3), 173178
Patients in our Doral clinic who complete both phases consistently report more visible skin texture changes than those who stop early